Dr. Lal PathLabs Limited (NSE:LALPATHLAB)
1,436.90
+18.30 (1.29%)
Apr 21, 2026, 2:00 PM IST
Dr. Lal PathLabs Market Cap
Dr. Lal PathLabs has a market cap or net worth of 237.06 billion as of April 20, 2026. Its market cap has increased by 16.22% in one year.
Market Cap
237.06B
Enterprise Value
225.94B
Revenue
26.63B
Ranking
n/a
PE Ratio
44.85
Stock Price
1,436.90
Market Cap Chart
Since December 23, 2015, Dr. Lal PathLabs's market cap has increased from 68.18B to 237.06B, an increase of 247.68%. That is a compound annual growth rate of 12.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 237.06B | -4.31% |
| Dec 31, 2025 | 247.75B | -0.90% |
| Dec 31, 2024 | 250.00B | 16.78% |
| Dec 29, 2023 | 214.08B | 14.42% |
| Dec 30, 2022 | 187.09B | -40.76% |
| Dec 31, 2021 | 315.81B | 66.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.02T |
| Divi's Laboratories | 1.65T |
| Apollo Hospitals Enterprise | 1.11T |
| Cipla | 1.00T |
| Krishna Institute of Medical Sciences | 272.95B |
| Inventurus Knowledge Solutions | 257.24B |
| Pfizer | 226.94B |
| Wockhardt | 226.73B |